Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22).

MLA

Tirrò, Elena, et al. “Efficacy of Nilotinib in a CML Patient Expressing the Three-Way Complex Variant Translocation t(2;9;22).” Anticancer Research, vol. 39, no. 7, July 2019, pp. 3893–99. EBSCOhost, https://doi.org/10.21873/anticanres.13540.

APA

Tirrò, E., Massimino, M., Stella, S., Zammit, V., Consoli, M. L., Pennisi, M. S., Vitale, S. R., Romano, C., Pirosa, M. C., Martino, E., DI Gregorio, S., Puma, A., DI Raimondo, F., Manzella, L., & Stagno, F. (2019). Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22). Anticancer Research, 39(7), 3893–3899. https://doi.org/10.21873/anticanres.13540

Chicago

Tirrò, Elena, Michele Massimino, Stefania Stella, Valentina Zammit, Maria Letizia Consoli, Maria Stella Pennisi, Silvia Rita Vitale, et al. 2019. “Efficacy of Nilotinib in a CML Patient Expressing the Three-Way Complex Variant Translocation t(2;9;22).” Anticancer Research 39 (7): 3893–99. doi:10.21873/anticanres.13540.